Abbott (ABT) Tops Q2 EPS by 1c, Beats on Revenue; Offers FY25 EPS Guidance

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/6/2026

1. USO
2. MRVL
3. SPY
4. NVDA
5. BBIO
6. GOOGL
7. CHRW
8. APLD
9. AMD
10. HUBS

Go back to Abbott (ABT) Tops Q2 EPS by 1c, Beats on Revenue; Offers FY25 EPS Guidance

Abbott Labs (ABT) PT Lowered to $155 at Citi

July 18, 2025 10:03 AM EDT

Citi analyst Joanna Wuensch lowered the price target on Abbott Labs (NYSE: ABT) to $155.00 (from $157.00) while maintaining a Buy rating.

The analyst comments "This was a somewhat precarious setup for ABT heading into the quarter, priced for a beat-and-raise, which did not... More

Goldman Sachs Reiterates Buy Rating on Abbott Labs (ABT)

July 17, 2025 9:45 AM EDT

Goldman Sachs analyst David Roman reiterated a Buy rating and $153.00 price target on Abbott Labs (NYSE: ABT).

The analyst comments "This morning, Abbott reported 2Q25 results and updated 2025 guidance. The headline that we expect to gain most attention is the reduction to the... More